Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 4/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | CCR2 | P41597 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27435508 | 0.92 | DRD3 (0.41) | KCNA3ALDH1A1DRD3DRD2BRD4 | |
| SCHEMBL30954067 | 0.92 | TP53 (0.42) | ALDH1A1KDM4EHSD17B10CCR2TP53 | |
| SCHEMBL27435254 | 0.92 | TP53 (0.42) | ALDH1A1KDM4EHSD17B10CCR2TP53 | |
| SCHEMBL27435374 | 0.91 | KCNA3 (0.43) | KCNA3ALDH1A1KDM4EHSD17B10DRD3 | |
| SCHEMBL30954054 | 0.91 | KCNA3 (0.43) | KCNA3ALDH1A1KDM4EHSD17B10DRD3 | |
| SCHEMBL27435005 | 0.88 | KCNA3 (0.42) | KCNA3BRD4CCR2ACACBTSHR | |
| SCHEMBL27435420 | 0.88 | ALDH1A1 (0.36) | ALDH1A1KDM4EHSD17B10DRD3DRD2 | |
| SCHEMBL30954048 | 0.88 | ALDH1A1 (0.36) | ALDH1A1KDM4EHSD17B10DRD3DRD2 | |
| SCHEMBL30954045 | 0.87 | POLB (0.42) | ALDH1A1KDM4EHSD17B10DRD3DRD2 | |
| SCHEMBL27433854 | 0.87 | POLB (0.42) | ALDH1A1KDM4EHSD17B10DRD3DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | claimed |
| EP-4630412-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024121130-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |